Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Transcriptional Adaptation and Genetic Compensation

Project description

Gaining more insight into the process of transcriptional adaptation

Organisms employ different mechanisms to compensate for the consequences of genetic perturbations. Recently discovered transcriptional adaptation (TA) is the process of transcriptional modulation of so-called adapting genes. Importantly, unlike other types of compensation, TA is not triggered by the loss of protein function. The EU-funded TAaGC project aims to investigate the mechanisms of TA, determining which genes are targeted as adapting and how the expression of these genes is modulated. The study will be carried out on zebrafish, nematode Caenorhabditis elegans, mice, and mouse and human cell lines, capitalising on the genetic and biochemical approaches specific for each model system. Furthermore, TAaGC will analyse the conservation of the TA mechanisms and investigate the relevance of TA in human health and disease.

Objective

Organisms utilize several mechanisms to compensate for the damaging consequences of genetic perturbations. One such mechanism is the newly identified process of transcriptional adaptation (TA): in this process, certain deleterious mutations trigger the transcriptional modulation of so-called adapting genes. In some cases, e.g. when one of the upregulated genes is functionally redundant with the mutated gene, TA leads to functional compensation. Notably, unlike other modes of compensation, TA is not triggered by the loss of protein function. This unexpected observation has prompted studies into the machinery of TA and the contexts in which it functions. Following our discovery of TA (Rossi et al., 2015), we have shown that in zebrafish embryos and mouse cell lines, mutant mRNA degradation triggers this process (El-Brolosy et al., 2019). We also observed TA in C. elegans and found that small RNA biogenesis, in addition to mutant mRNA degradation, is required for this process (Serobyan et al., 2020). While these and other studies have documented the importance of TA and its occurrence across phylogenetically distant organisms, several key questions remain in terms of how TA arises and how prevalent it is. In this proposal, we aim to investigate the mechanisms that underlie TA, including 1) what determines which genes are targeted as adapting genes during TA, and 2) how the expression of these genes is modulated during TA. These studies will be carried out in zebrafish, C. elegans, mice, and multiple mouse and human cell lines, capitalizing on the genetic and biochemical approaches available in each model system, while simultaneously allowing us to analyze the conservation of the mechanisms underlying TA. In addition, we will investigate the relevance of TA in human health and disease. Ultimately, this work will further our understanding of the mechanisms that modulate genetic and phenotypic robustness in humans.

Host institution

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 2 500 000,00
Address
HOFGARTENSTRASSE 8
80539 Munchen
Germany

See on map

Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Research Organisations
Links
Total cost
€ 2 500 000,00

Beneficiaries (1)